Rewired ERK-JNK Signaling Pathways in Melanoma

Cancer Cell

Volumn 11, Issue 5, 2007, Pages 447-460

  Lopez Bergami, Pablo ^a,b   Huang, Conway ^c   Goydos, James S ^d   Yip, Dana ^d   Bar Eli, Menashe ^e   Herlyn, Meenhard ^f   Smalley, Keiran S M ^f   Mahale, Alka ^b   Eroshkin, Alexey ^a   Aaronson, Stuart ^b   Ronai, Ze'ev ^a  

^a BURNHAM INSTITUTE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f WISTAR INSTITUTE   (United States)

Author keywords

SIGNALING

Indexed keywords

ADAPTOR PROTEIN; ADAPTOR PROTEIN RACK1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN D1; GLYCOGEN SYNTHASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C JUN; PROTEIN KINASE C; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEEDBACK SYSTEM; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 34247606483     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2007.03.009     Document Type: Article

References (60)

1. Ahn S., Olive M., Aggarwal S., Krylov D., Ginty D.D., and Vinson C. A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulus-dependent transcription of c-fos. Mol. Cell. Biol. 18 (1998) 967-977
2. Alsina J., Gorsk D.H., Germino F.J., Shih W., Lu S.E., Zhang Z.G., Yang J.M., Hait W.N., and Goydos J.S. Detection of mutations in the mitogen-activated protein kinase pathway in human melanoma. Clin. Cancer Res. 9 (2003) 6419-6425
3. Angel P., Hattori K., Smeal T., and Karin M. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55 (1988) 875-885
4. Bain J., McLauchlan H., Elliott M., and Cohen P. The specificities of protein kinase inhibitors: An update. Biochem. J. 371 (2003) 199-204
5. Bartek J., Staskova Z., Draetta G., and Lukas J. Molecular pathology of the cell cycle in human cancer cells. Stem Cells 11 (1993) 51-58
6. Bartek J., Bartkova J., and Lukas J. The retinoblastoma protein pathway and the restriction point. Curr. Opin. Cell Biol. 8 (1996) 805-814
7. Berns H., Humar R., Hengerer B., Kiefer F.N., and Battegay E.J. RACK1 is up-regulated in angiogenesis and human carcinomas. FASEB J. 14 (2000) 2549-2558
8. Bhoumik A., Jones N., and Ronai Z. Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicity. Proc. Natl. Acad. Sci. USA 101 (2004) 4222-4227
9. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 13 (2000) 239-252
10. Davies S.P., Reddy H., Caivano M., and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351 (2000) 95-105
11. Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., Clegg S., Teague J., Woffendin H., Garnett M.J., Bottomley W., et al. Mutations in the B-RAF gene in human cancer. Nature 417 (2002) 949-954
12. Ding Q., Xia W., Liu J.C., Yang J.Y., Lee D.F., Xia J., Bartholomeusz G., Li Y., Pan Y., Li Z., et al. Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. Mol. Cell 19 (2005) 159-170
13. Downward J. Targeting RAS signaling pathways in cancer therapy. Nat. Rev. Cancer 3 (2003) 11-12
14. Dumont J.A., Jones Jr. W.D., and Bitonti A.J. Inhibition of experimental metastasis and cell adhesion of B16F1 melanoma cells by inhibitors of protein kinase C. Cancer Res. 52 (1992) 1195-1200
15. Eferl R., Ricci R., Kenner L., Zenz R., David J.P., Rath M., and Wagner E.F. Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell 112 (2003) 181-192
16. Errico M.E., Staibano S., Tranfa F., Bonavolonta G., Lo Muzio L., Somma P., Lucariello A., Mansueto G., D'Aponte A., Ferrara G., et al. Expression of cyclin-D1 in uveal malignant melanoma. Anticancer Res. 23 (2003) 2701-2706
17. Fuchs S.Y., Dolan L., Davis R.J., and Ronai Z. Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase. Oncogene 13 (1996) 1531-1535
18. Gorden A., Osman I., Gai W., He D., Huang W., Davidson A., Houghton A.N., Busam K., and Polsky D. Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues. Cancer Res. 63 (2003) 3955-3957
19. Goydos J.S., Mann B., Kim H.J., Gabriel E.M., Alsina J., Germino F.J., Shih W., and Gorski D.H. Detection of B-RAF and N-RAS mutations in human melanoma. J. Am. Coll. Surg. 200 (2005) 362-370
20. Gupta P., and Prywes R. ATF1 phosphorylation by the ERK MAPK pathway is required for epidermal growth factor-induced c-jun expression. J. Biol. Chem. 277 (2002) 50550-50556
21. Ivanov V.N., Bhoumik A., Krasilnikov M., Raz R., Owen-Schaub L.B., Levy D., Horvath C.M., and Ronai Z. Cooperation between STAT3 and c-jun suppresses Fas transcription. Mol. Cell 7 (2001) 517-528
22. Johannessen M., Delghandi M.P., and Moens U. What turns CREB on?. Cell. Signal. 16 (2004) 1211-1227
23. Johnson G.L., and Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298 (2002) 1911-1912
24. Johnson R., Spiegelman B., Hanahan D., and Wisdom R. Cellular transformation and malignancy induced by ras require c-jun. Mol. Cell. Biol. 16 (1996) 4504-4511
25. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270 (1995) 16483-16486
26. Laine A., and Ronai Z. Ubiquitin chains in the ladder of MAPK signaling. Sci. STKE 281 (2005) re5
27. Li G., Kalabis J., Xu X., Meier F., Oka M., Bogenrieder T., and Herlyn M. Reciprocal regulation of MelCAM and AKT in human melanoma. Oncogene 22 (2003) 6891-6899
28. Liu J., Yang D., Minemoto Y., Leitges M., Rosner M.R., and Lin A. NF-kappaB is required for UV-induced JNK activation via induction of PKCdelta. Mol. Cell 21 (2006) 467-480
29. Lopez-Bergami P., Habelhah H., Bhoumik A., Zhang W., Wang L.H., and Ronai Z. RACK1 mediates activation of JNK by protein kinase C. Mol. Cell 19 (2005) 309-320
30. Lopez-Bergami P., Bhoumik A., and Ronai Z. Altered Signal Transduction in Melanoma. In: Hearing V.J., and Leong S.P.L. (Eds). From Melanocytes to Malignant Melanoma (2005), Humana Press, Totowa, New Jersey 119-147
31. Maelandsmo G.M., Florenes V.A., Hovig E., Oyjord T., Engebraaten O., Holm R., Borresen A.L., and Fodstad O. Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas. Br. J. Cancer 73 (1996) 909-916
32. Maldonado J.L., Fridlyand J., Patel H., Jain A.N., Busam K., Kageshita T., Ono T., Albertson D.G., Pinkel D., and Bastian B.C. Determinants of BRAF mutations in primary melanomas. J. Natl. Cancer Inst. 95 (2003) 1878-1890
33. Mathas S., Hinz M., Anagnostopoulos I., Krappmann D., Lietz A., Jundt F., Bommert K., Mechta-Grigoriou F., Stein H., Dorken B., et al. Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B. EMBO J. 21 (2002) 4104-4113
34. Mapelli E., Banfi P., Sala E., Sensi M., Supino R., Zunino F., and Gambetta R.A. Effect of protein kinase C inhibitors on invasiveness of human melanoma clones expressing different levels of protein kinase C isoenzymes. Int. J. Cancer 57 (1994) 281-286
35. Minden A., Lin A., Smeal B., Derijard M., Cobb R., Davis R., and Karin M. c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinase. Mol. Cell. Biol. 14 (1994) 6683-6688
36. Molina D.M., Grewal S., and Bardwell L. Characterization of an ERK-binding domain in microphthalmia-associated transcription factor and differential inhibition of ERK2-mediated substrate phosphorylation. J. Biol. Chem. 280 (2005) 42051-42060
37. Morton S., Davis R.J., McLaren A., and Cohen P. A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J. 22 (2003) 3876-3886
38. Murphy L.O., and Blenis J. MAPK signal specificity: The right place at the right time. Trends Biochem. Sci. 31 (2006) 268-275
39. Nyormoi O., and Bar-Eli M. Transcriptional regulation of metastasis-related genes in human melanoma. Clin. Exp. Metastasis 20 (2003) 251-263
40. Oka M., and Kikkawa U. Protein kinase C in melanoma. Cancer Metastasis Rev. 24 (2005) 287-300
41. Pardo M., Pineiro A., de la Fuente M., Garcia A., Prabhakar S., Zitzmann N., Dwek R.A., Sanchez-Salorio M., Dominguez F., and Capeans C. Abnormal cell cycle regulation in primary human uveal melanoma cultures. J. Cell Biochem. 93 (2004) 708-720
42. Park C.H., Lee M.J., Ahn J., Kim S., Kim H.H., Kim K.H., Eunm H.C., and Chung J.H. Heat shock-induced matrix metalloproteinase (MMP)-1 and MMP-3 are mediated through ERK and JNK activation and via an autocrine interleukin-6 loop. J. Invest. Dermatol. 123 (2004) 1012-1019
43. Pollock P.M., and Meltzer P.S. A genome-based strategy uncovers frequent BRAF mutations in melanoma. Cancer Cell 2 (2002) 5-7
44. Ron D., Chen C.H., Caldwell J., Jamieson L., Orr E., and Mochly-Rosen D. Cloning of an intracellular receptor for protein kinase C, a homolog of the beta subunit of G proteins. Proc. Natl. Acad. Sci. USA 91 (1994) 839-843
45. Sabbah M., Courilleau D., Mester J., and Redeuilh G. Estrogen induction of the cyclin D1 promoter: Involvement of a cAMP response-like element. Proc. Natl. Acad. Sci. USA 96 (1999) 11217-11222
46. Saito A., Fujii G., Sato Y., Gotoh M., Sakamoto M., Toda G., and Hirohashi S. Detection of genes expressed in primary colon cancers by in situ hybridisation, overexpression of RACK 1. Mol. Pathol. 55 (2002) 34-39
47. Satyamoorthy K., DeJesus E., Linnenbach A.J., Kraj B., Kornreich D.L., Rendle S., Elder D.E., and Herlyn M. Melanoma cell lines from different stages of progression and their biological and molecular analyses. Melanoma Res. 7 (1997) S35-S42
48. Satyamoorthy K., Li G., Gerrero M.R., Brose M.S., Volpe P., Weber B.L., van Belle P., Elder D.R., and Herlyn M. Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation. Cancer Res. 63 (2003) 756-759
49. Sauter E.R., Yeo U.C., von Stemm A., Zhu W., Litwin S., Tichansky D.S., Pistritto G., Nesbit M., Pinkel D., Herlyn M., Bastian B.C., et al. Cyclin D1 is a candidate oncogene in cutaneous melanoma. Cancer Res. 62 (2002) 3200-3206
50. Schechtman D., and Mochly-Rosen D. Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene 20 (2001) 6339-6347
51. Selzer E., Okamoto I., Lucas T., Kodym R., Pehamberger H., and Jansen B. Protein kinase C isoforms in normal and transformed cells of the melanocytic lineage. Melanoma Res. 12 (2002) 201-209
52. Seo J., and Shneiderman B. Interactively exploring hierarchical clustering Results. IEEE Computer 35 (2002) 80-86
53. Shaulian E., and Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4 (2002) 131-136
54. Sprowles A., Robinson D., Wu Y.M., Kung H.J., and Wisdom R. c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases. Exp. Cell Res. 308 (2005) 459-468
55. Tanami H., Imoto I., Hirasawa A., Yuki Y., Sonoda I., Inoue J., Yasui K., Misawa-Furihata A., Kawakami Y., and Inazawa J. Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines. Oncogene 23 (2004) 8796-8804
56. Utikal J., Udart M., Leiter U., Peter R.U., and Krahn G. Additional Cyclin D(1) gene copies associated with chromosome 11 aberrations in cutaneous malignant melanoma. Int. J. Oncol. 26 (2005) 597-605
57. Vogt P.K. Jun, the oncoprotein. Oncogene 20 (2001) 2365-2377
58. Wei W., Jin J., Schlisio S., Harper J.W., and Kaelin Jr. W.G. The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase. Cancer Cell 8 (2005) 25-33
59. Weston C.R., and Davis R.J. The JNK signal transduction pathway. Curr. Opin. Genet. Dev. 12 (2002) 14-21
60. Wiggin G.R., Soloaga A., Foster J.M., Murray-Tait V., Cohen P., and Arthur J.S. MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts. Mol. Cell. Biol. 22 (2002) 2871-2881